CeriBell Sets New 1-Year High After Analyst Upgrade
| CBLL Stock | 29.20 0.41 1.38% |
About 56% of CeriBell,'s investor base is looking to short. The analysis of overall sentiment of trading CeriBell, stock suggests that many investors are alarmed at this time. CeriBell,'s investing sentiment shows overall attitude of investors towards CeriBell,.
CeriBell, |
Shares of CeriBell hit a new 52-week high during mid-day trading on Monday after TD Cowen raised their price target on the stock from 31.00 to 36.00. TD Cowen currently has a buy rating on the stock. CeriBell traded as high as 31.82 and last traded at 31.82, with a
Read at thelincolnianonline.com
 |
CeriBell, Fundamental Analysis
We analyze CeriBell,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CeriBell, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CeriBell, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
CeriBell, is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
CeriBell, Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CeriBell, stock to make a market-neutral strategy. Peer analysis of CeriBell, could also be used in its relative valuation, which is a method of valuing CeriBell, by comparing valuation metrics with similar companies.
Peers
CeriBell, Related Equities
| ICAD | Icad | 4.23 | ||||
| SNN | Smith Nephew | 0.31 | ||||
| GMED | Globus Medical | 0.28 | ||||
| MYO | Myomo | 0.31 | ||||
| IINN | Inspira Technologies | 0.83 | ||||
| ZIMV | ZimVie | 2.38 | ||||
| XYLO | Xylo Technologies | 3.68 | ||||
| QTI | QT Imaging | 4.00 | ||||
| HSDT | Helius Medical | 8.62 | ||||
| WOK | WORK Medical | 21.50 |
Check out CeriBell, Hype Analysis, CeriBell, Correlation and CeriBell, Performance. For more information on how to buy CeriBell, Stock please use our How to buy in CeriBell, Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CeriBell,. If investors know CeriBell, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CeriBell, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CeriBell, is measured differently than its book value, which is the value of CeriBell, that is recorded on the company's balance sheet. Investors also form their own opinion of CeriBell,'s value that differs from its market value or its book value, called intrinsic value, which is CeriBell,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CeriBell,'s market value can be influenced by many factors that don't directly affect CeriBell,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CeriBell,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if CeriBell, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CeriBell,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.